79 results
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:20pm
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets … and
Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:17pm
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets … and
Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would
424B3
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Prospectus supplement
5:15pm
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets … and
Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would
8-K
EX-10.1
CMRA
Comera Life Sciences Holdings, Inc.
29 Dec 23
Entry into a Material Definitive Agreement
5:00pm
as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability, (iii) access to assets … and
Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification, except as would
424B3
EX-99.1
CMRA
Comera Life Sciences Holdings, Inc.
6 Dec 23
Prospectus supplement
8:37am
Holdings, Inc. (OTCQB: CMRA) (“Comera” or the “Company”), a life sciences company developing a new generation of biologic medicines to improve patient access
424B3
EX-99.1
urd7hb0hw9syq7
6 Dec 23
Prospectus supplement
8:34am
424B3
EX-99.1
j409hh9o4cqpcq ia07
6 Dec 23
Prospectus supplement
8:32am
8-K
EX-99.1
yn3eeoddp2mrd7at
6 Dec 23
Comera Life Sciences Announces Process Exploring Strategic Alternatives
8:30am
424B3
22bdcxn0gq4ivhw8q
9 Nov 23
Prospectus supplement
4:36pm
424B3
28qhb8l10b77c1e0trf
9 Nov 23
Prospectus supplement
4:35pm
424B3
cr3ovj054dq7wp5xe
9 Nov 23
Prospectus supplement
4:33pm
8-K
EX-99.1
2q0nk crn57x
9 Nov 23
Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights
4:31pm
DEF 14A
1fjhqg68l3x18xd
11 Aug 23
Definitive proxy
4:15pm
8-K
EX-99.1
aeirag iky0hor
10 Aug 23
Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights
5:30pm
424B3
pxk4qj22xj4a
10 Aug 23
Prospectus supplement
4:37pm
424B3
04aru
10 Aug 23
Prospectus supplement
4:32pm
424B3
5gwg6zv8p8a3306s
10 Aug 23
Prospectus supplement
4:32pm
PRE 14A
egz852jmtqndx8i5p
1 Aug 23
Preliminary proxy
5:08pm